Reports for HIKMA CANADA LIMITED
Company Name
HIKMA CANADA LIMITED
Totals |
||
Shortage reports |
82 |
|
| Actual shortage: | 12 (15%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 1 (1%) | |
| Resolved: | 69 (84%) | |
Discontinuation Reports |
4 |
|
| To be discontinued: | 3 (75%) | |
| Discontinued: | 1 (25%) | |
| Reversed: | 0 (0%) | |
Late reports |
16 (19%) |
|
Overdue reports |
10 (67%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| EPINEPHRINE INJECTION USP | 1MG | SOLUTION | Resolved | 2022-06-20 | 2022-08-16 | 163112 |
| ACETYLCYSTEINE SOLUTION USP | 200MG | SOLUTION | Resolved | 2022-10-06 | 2023-06-02 | 171228 |
| ACETYLCYSTEINE SOLUTION USP | 200MG | SOLUTION | Avoided shortage | 2022-10-21 | 2023-06-14 | 172409 |
| NALOXONE INJECTABLE | 0.4MG | SOLUTION | Resolved | 2022-12-05 | 2022-12-31 | 177165 |
| CEFAZOLIN FOR INJECTION | 10G | POWDER FOR SOLUTION | Resolved | 2023-01-27 | 2023-07-06 | 182608 |
| CEFAZOLIN FOR INJECTION | 1G | POWDER FOR SOLUTION | Resolved | 2023-02-02 | 2023-05-08 | 183209 |
| SUCCINYLCHOLINE CHLORIDE INJECTION USP | 20MG | SOLUTION | Resolved | 2023-04-17 | 2023-09-05 | 189738 |
| BACLOFEN INJECTION | 0.05MG | SOLUTION | Actual shortage | 2023-05-26 | 2023-05-27 | 193244 |
| SUCCINYLCHOLINE CHLORIDE INJECTION USP | 20MG | SOLUTION | Resolved | 2023-05-26 | 2024-02-01 | 193247 |
| LATANOPROST AND TIMOLOL OPHTHALMIC SOLUTION | 5MG 50MCG | SOLUTION | Actual shortage | 2023-06-06 | 2023-06-27 | 193838 |
| EPINEPHRINE INJECTION USP | 1MG | SOLUTION | Resolved | 2023-08-03 | 2024-03-28 | 200978 |
| CYANOCOBALAMIN INJECTION USP | 1000MCG | SOLUTION LIQUID | Resolved | 2023-08-03 | 2023-12-15 | 200983 |
| SUCCINYLCHOLINE CHLORIDE INJECTION USP | 20MG | SOLUTION | Resolved | 2023-10-02 | 2024-01-30 | 205822 |
| FENTANYL CITRATE INJECTION USP | 50MCG | SOLUTION | Actual shortage | 2023-10-02 | 2023-11-02 | 205826 |
| LIDOCAINE HYDROCHLORIDE INJECTION USP | 10MG | SOLUTION | Resolved | 2023-10-20 | 2024-03-06 | 207616 |
| LIDOCAINE HYDROCHLORIDE INJECTION USP | 10MG | SOLUTION | Resolved | 2023-10-20 | 2024-04-09 | 207619 |
| NALOXONE HYDROCHLORIDE INJECTION USP | 0.4MG | SOLUTION | Actual shortage | 2023-11-17 | 2024-05-13 | 210664 |
| DIMENHYDRINATE INJECTION USP | 50MG | SOLUTION | Actual shortage | 2023-11-17 | 2024-05-13 | 210671 |
| FUROSEMIDE INJECTION USP | 20MG | SOLUTION | Resolved | 2023-11-17 | 2024-02-14 | 210680 |
| ATROPINE INJECTION BP | 0.4MG | SOLUTION | Resolved | 2023-11-17 | 2024-04-16 | 210686 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| PIPERACILLIN AND TAZOBACTAM FOR INJECTION | 2G 0.25G | POWDER FOR SOLUTION | To be discontinued | 2022-07-21 | 2022-07-21 | 165188 |
| PIPERACILLIN AND TAZOBACTAM FOR INJECTION | 0.375G 3G | POWDER FOR SOLUTION | To be discontinued | 2022-07-21 | 2022-07-21 | 165193 |
| PIPERACILLIN AND TAZOBACTAM FOR INJECTION | 0.5G 4G | POWDER FOR SOLUTION | To be discontinued | 2022-07-21 | 2022-07-21 | 165196 |
| LIDOCAINE HYDROCHLORIDE INJECTION USP | 10MG | SOLUTION | Discontinued | 2024-04-19 | 2024-04-22 | 225805 |
Showing 1 to 4 of 4